QR Pharma and UCLA Awarded $3 Million USARMY Grant to Test Posiphen® in Rat Models of Concussion and Blunt Head Trauma
Read more here


Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise in Series A Financing
Read more here


Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio
Read more here